StockData
MaxCyte, Inc. logo

MaxCyte, Inc. (MXCT) stock

MXCTNasdaqServices-Commercial Physical & Biological ResearchFiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 10, 2026Score 9/3064% below fair value
$1.25+0.08 (+6.84%)

Close on Nov 18, 2026Market cap $129.01MP/E –Yield –

MaxCyte free cash flow

Free cash flow is cash from operations minus capital expenditures: the cash available for dividends, buybacks, debt repayment or acquisitions.

MaxCyte's free cash flow for the twelve months ending Jun 30, 2026 was -$23.64M. For fiscal 2025 it was -$36.18M. The highest annual figure on record is -$10.07M in fiscal 2019.

Annual free cash flow

PeriodPeriod endValueChange
FY2025Dec 31, 2025-$36.18M–
FY2024Dec 31, 2024-$29.26M–
FY2023Dec 31, 2023-$25.39M–
FY2022Dec 31, 2022-$33.26M–
FY2021Dec 31, 2021-$14.51M–
FY2020Dec 31, 2020-$10.85M–
FY2019Dec 31, 2019-$10.07M–

Quarterly free cash flow

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026-$4.72M–
Q1 FY2026Mar 31, 2026-$8.24M–
Q4 FY2025Dec 31, 2025-$2.92M–
Q3 FY2025Sep 30, 2025-$7.76M–
Q2 FY2025Jun 30, 2025-$10.44M–
Q1 FY2025Mar 31, 2025-$15.06M–
Q4 FY2024Dec 31, 2024-$7.97M-12172.7%
Q3 FY2024Sep 30, 2024-$4.80M–
Q2 FY2024Jun 30, 2024-$5.13M–
Q1 FY2024Mar 31, 2024-$11.37M–
Q4 FY2023Dec 31, 2023$66.00K–
Q3 FY2023Sep 30, 2023-$8.96M–
Q2 FY2023Jun 30, 2023-$10.61M–
Q1 FY2023Mar 31, 2023-$5.88M–
Q4 FY2022Dec 31, 2022-$8.28M–
Q3 FY2022Sep 30, 2022-$9.40M–
Q2 FY2022Jun 30, 2022-$5.89M–
Q1 FY2022Mar 31, 2022-$9.69M–
Q4 FY2021Dec 31, 2021-$2.08M–
Q3 FY2021Sep 30, 2021-$2.13M–
Q2 FY2021Jun 30, 2021-$5.35M–
Q1 FY2021Mar 31, 2021-$4.95M–
Q4 FY2020Dec 31, 2020-$2.27M–
Q3 FY2020Sep 30, 2020-$1.49M–

More MaxCyte figures

See a number that looks wrong?